Novel hormonal therapies in the management of advanced prostate cancer: extrapolating Asian findings to Southeast Asia.

Ong, Teng Aik; Saad, Marniza; Lim, Jasmine; Lee, Hsien Hooi

Ong, Teng Aik; Saad, Marniza; Lim, Jasmine; Lee, Hsien Hooi.

Ong TA; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Saad M; Department of Clinical Oncology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. marniza@ummc.edu.my.
Lim J; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Lee HH; Johnson & Johnson Pte. Ltd., Petaling Jaya, Selangor, Malaysia.

BMC Urol ; 23(1): 4, 2023 Jan 06.

Article en En | MEDLINE | ID: mdl-36609251

Asunto(s)

Neoplasias de la Próstata Resistentes a la Castración; Neoplasias de la Próstata; Masculino; Humanos; Feniltiohidantoína/uso terapéutico; Neoplasias de la Próstata/tratamiento farmacológico; Benzamidas/uso terapéutico; Acetato de Abiraterona; Asia Sudoriental; Neoplasias de la Próstata Resistentes a la Castración/tratamiento farmacológico

Palabras clave

Abiraterone acetate; Advanced prostate cancer; Apalutamide; Darolutamide; Enzalutamide; New generation androgen receptor-axis targeted therapies; Southeast Asia

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Diagnostic_studies Límite: Humans / Male País como asunto: Asia Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google